Literature DB >> 17077087

p53 suppresses the Nrf2-dependent transcription of antioxidant response genes.

Raffaella Faraonio1, Paola Vergara, Domenico Di Marzo, Maria Giovanna Pierantoni, Maria Napolitano, Tommaso Russo, Filiberto Cimino.   

Abstract

Cells respond to the shift of intracellular environment toward pro-oxidant conditions by activating the transcription of numerous "antioxidant" genes. This response is based on the activation of the Nrf2 transcription factor, which transactivates the genes containing in their promoters the antioxidant response cis-elements (AREs). If the oxidative stress provokes DNA damage, a second response of the cell takes place, based on the activation of p53, which induces cell cycle arrest and/or apoptosis. Here we have explored the cross-talk between these two regulatory mechanisms. The results show that p53 counteracts the Nrf2-induced transcription of three ARE-containing promoters of the x-CT, NQO1, and GST-alpha1 genes. Endogenous transcripts of these antioxidant genes accumulate as a consequence of Nrf2 overexpression or exposure to electrophile diethylmaleate, but these effects are again blocked by p53 overexpression or endogenous p53 activation. Chromatin immunoprecipitation experiments support the hypothesis that this p53-dependent trans-repression is due to the direct interaction of p53 with the ARE-containing promoters. Considering that p53-induced apoptosis requires an accumulation of reactive oxygen species, this negative control on the Nrf2 transactivation appears to be aimed to prevent the generation of a strong anti-oxidant intracellular environment that could hinder the induction of apoptosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17077087     DOI: 10.1074/jbc.M605707200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  135 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 2.  p53, oxidative stress, and aging.

Authors:  Dongping Liu; Yang Xu
Journal:  Antioxid Redox Signal       Date:  2011-02-07       Impact factor: 8.401

3.  p53-regulated increase in oxidative-stress--induced apoptosis in Fuchs endothelial corneal dystrophy: a native tissue model.

Authors:  Behrooz Azizi; Alireza Ziaei; Thomas Fuchsluger; Thore Schmedt; Yuming Chen; Ula V Jurkunas
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-02       Impact factor: 4.799

Review 4.  NRF2 and the Hallmarks of Cancer.

Authors:  Montserrat Rojo de la Vega; Eli Chapman; Donna D Zhang
Journal:  Cancer Cell       Date:  2018-05-03       Impact factor: 31.743

Review 5.  The Keap1-Nrf2 pathway: promising therapeutic target to counteract ROS-mediated damage in cancers and neurodegenerative diseases.

Authors:  Prashant Deshmukh; Sruthi Unni; Gopinatha Krishnappa; Balasundaram Padmanabhan
Journal:  Biophys Rev       Date:  2016-12-06

6.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

7.  Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer line.

Authors:  Nektarios Barabutis; Andrew V Schally
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

8.  The effects of phototherapy and melanocytes on keratinocytes.

Authors:  Luyan Tang; Wenyu Wu; Wenwen Fu; Yao Hu
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

9.  The polycomb group gene Bmi1 regulates antioxidant defenses in neurons by repressing p53 pro-oxidant activity.

Authors:  Wassim Chatoo; Mohamed Abdouh; Jocelyn David; Marie-Pier Champagne; José Ferreira; Francis Rodier; Gilbert Bernier
Journal:  J Neurosci       Date:  2009-01-14       Impact factor: 6.167

10.  Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels.

Authors:  Hui-Xian Zhang; Yang Chen; Rong Xu; Qi-Yang He
Journal:  Acta Pharmacol Sin       Date:  2018-05-10       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.